Canada - English - Health Canada

bayer inc - riociguat - tablet - 2mg - riociguat 2mg - vasodilating agents

Canada - English - Health Canada

bayer inc - riociguat - tablet - 2.5mg - riociguat 2.5mg - vasodilating agents

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sildenafil citrate, quantity: 35.11 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; croscarmellose sodium; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; brilliant blue fcf aluminium lake; polyvinyl alcohol; quinoline yellow aluminium lake; macrogol 3350 - sildenafil is indicated for the treatment of erectile dysfunction in adult males.,it is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - sildenafil citrate, quantity: 35.1 mg (equivalent: sildenafil, qty 25 mg) - tablet, uncoated - excipient ingredients: indigo carmine aluminium lake; magnesium stearate; copovidone; microcrystalline cellulose; saccharin sodium; calcium hydrogen phosphate; croscarmellose sodium - sildenafil sandoz is indicated for the treatment of erectile dysfunction in adult males. sildenafil sandoz is not indicated for use by women.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - sildenafil citrate, quantity: 35.11 mg (equivalent: sildenafil, qty 25 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; calcium hydrogen phosphate; croscarmellose sodium; magnesium stearate; titanium dioxide; lactose monohydrate; hypromellose; indigo carmine; triacetin; vanillin; biotin - viagra is indicated for the treatment of erectile dysfunction in adult males. viagra is not indicated for use by women.

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bayer ag - riociguat - riociguat....2.5 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bayer ag - riociguat - riociguat....2 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bayer ag - riociguat - riociguat....1.5mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

bayer ag - riociguat - riociguat....0.5mg

New Zealand - English - Medsafe (Medicines Safety Authority)

bayer new zealand limited - riociguat 0.5mg - film coated tablet - 0.5 mg - active: riociguat 0.5mg excipient: crospovidone hyprolose hypromellose   lactose monohydrate magnesium stearate microcrystalline cellulose propylene glycol purified water sodium laurilsulfate titanium dioxide - pulmonary arterial hypertension adempas, as monotherapy or in combination with approved pah treatments (endothelin receptor agonists or inhaled or subcutaneous prostanoids ), is indicated for the treatment of: - idiopathic pulmonary arterial hypertension - heritable pulmonary arterial hypertension - pulmonary arterial hypertension associated with connective tissue diseases - pulmonary arterial hypertension associated with congenital heart disease in adult patients with who functional class ii, iii or iv symptoms.